Results 121 to 130 of about 3,216,606 (307)

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Beyond antimicrobials: Ecological nano‐strategies for rebalancing dysbiotic oral microbial homeostasis

BMEMat, EarlyView.
Oral microbial homeostasis, a dynamic host‐microbe balance, is vital in infectious diseases. Conventional antibiotics often disrupt this homeostasis, spurring interest in nanomaterials for oral microbial homeostasis rebalancing. This review outlines nanomaterial strategies across three ecological levels (population/community, ecosystem, and cross ...
Chen Hu, Aohan Luan, Yujun Yang, Linlin Wang, Huilin Wang, Ning Wang, Guixin He, Yajie Yang, Rabiya Noor, Jawad Hussain, Longquan Shao   +10 more
wiley   +1 more source

Clinical and Functional Features of Acute Coronary Syndrome in Patients with Concomitant Type 2 Diabetes Mellitus

, 2016
Introduction. According to various international registries, the proportion of patients with type 2 diabetes mellitus in a cohort of patients with acute coronary syndrome ranges from 22.0 to 34.0 %.
Kyyak H.
core   +1 more source

Five‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer Drug‐Eluting Stents: A Propensity Score‐Matched Analysis of 4394 Patients

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Biodegradable‐polymer (BP) drug‐eluting stents (DES) were developed to mitigate potential late adverse events related to persistent durable polymers in durable‐polymer (DP) DES; however, contemporary long‐term real‐world comparative data remain limited. Aims We aimed to compare the 5‐year clinical outcomes of contemporary BP‐DES and
Yangyoun Lee, Hong‐Seok Lim, Kyoung‐Woo Seo, Hyoung‐Mo Yang, So‐Yeon Choi, Seung‐Jea Tahk, Myeong‐Ho Yoon   +6 more
wiley   +1 more source

Acute coronary syndromes [PDF]

Srce i krvni sudovi, 2012
Charles, Knight, Adam D, Timmis
openaire   +2 more sources

Unprotected Left Main Disease: Clinical Outcomes Following Deferral, Coronary Artery Bypass Grafting, or Percutaneous Coronary Intervention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The prognostic benefit of revascularization for unprotected left main (LM) disease remains uncertain, as guideline endorsement of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) precludes comparison with deferral, which is unlikely to be assessed in a randomized trial.
Marc Meller Bröchner, Evald Høj Christiansen, Kristian Kragholm, Lisette Okkels Jensen, Gennady Atroshchenko, Ivy Susanne Modrau, Lars Riber, Oliver Buchhave Pedersen, Leif Thuesen, Christian Torp‐Pedersen, Ashkan Eftekhari   +10 more
wiley   +1 more source

Relationship between NAFLD and coronary artery disease: A Mendelian randomization study

Hepatology, EarlyView., 2022
Abstract Background and Aims There is an ongoing debate on whether NAFLD is an active contributor or an innocent bystander in the pathogenesis of coronary artery disease (CAD). The aim of the present study was to assess the causal relationship between NAFLD and CAD.
Zhewen Ren, Pomme I. H. G. Simons, Anke Wesselius, Coen D. A. Stehouwer, Martijn C. G. J. Brouwers   +4 more
wiley   +1 more source

A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases

Cardiovascular Therapeutics
Conclusion: Statins’ adverse reactions differ across populations. For those with hypercholesterolemia and diabetes, statins’ impact on transaminase levels is similar. Yet patients with coronary heart disease, acute coronary syndrome, or acute stroke show
Wanying Li, Ding Wang, Caiyue Lin, Tongze Cai, Mei Zhao, Liuguan Liang, Xingxing Zhao, Xin He, Xiaoyue Liang, Jinghui Zheng   +9 more
doaj   +1 more source

Age related differences in acute coronary syndrome presentation and in hospital outcomes. A cross-sectional comparative study

The Pan African Medical Journal, 2016
Coronary artery disease is prevalent worldwide and causing much morbidity and mortality, it causes 12.7% of death across the earth; the burden is involving all countries and communities .
Hyder Osman Mirghani
doaj   +1 more source

Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome

, 2017
Background: The optimal duration of dual antiplatelet therapy after percutaneous coronary intervention (PCI) remains uncertain. The objective of this study was to examine the association between duration of dual antiplatelet therapy and re ...
李啟明;高純琇;蕭斐元, Chen, Shih-Chin;Hsiao, Fei-Yuan;Lee, Chii-Ming;Hsu, William Wei-Yuan;Gau, Churn-Shiouh   +1 more
core   +1 more source